Idera Pharmaceuticals, Inc. (IDRA): $1.04

-0.01 (-0.95%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add IDRA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 496

in industry

Idera Pharmaceuticals Inc (IDRA) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering IDRA.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
1 $1 $1 $1 $1.08 -7.41%

Price Target Last Issued May 8, 2021

The Trend in the Analyst Price Target


Over the past 105 days, IDRA's average price target has gone down $6.83.

IDRA reports an average of 81.32% for its upside potential over the past 346 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-08 1 1 1 1.00 1.08 -7.41%
2021-04-25 2 2 1 1.50 1.13 32.74%
2021-04-17 2 2 1 1.50 1.10 36.36%
2021-04-10 2 2 1 1.50 1.34 11.94%
2021-04-03 2 2 1 1.50 1.32 13.64%
2021-03-20 2 2 1 1.50 1.98 -24.24%
2021-03-13 5 10 7 8.60 4.87 76.59%
2021-03-06 6 10 7 8.33 4.16 100.24%
2021-02-27 6 10 5 7.83 4.36 79.59%
2021-02-20 6 10 5 7.83 4.76 64.5%
2021-02-13 6 10 5 7.83 5.07 54.44%
2021-02-06 6 10 5 7.83 5.27 48.58%
2021-01-30 6 10 5 7.83 5.59 40.07%
2021-01-23 6 10 5 7.83 5.95 31.6%
2021-01-16 6 10 5 7.83 4.48 74.78%
2021-01-09 6 10 5 7.83 4.28 82.94%
2021-01-02 6 10 5 7.83 3.67 113.35%
2020-12-26 6 10 5 7.83 4.26 83.8%
2020-12-19 6 10 5 7.83 4.25 84.24%
2020-12-09 6 10 5 7.83 4.69 66.95%
2020-12-07 6 10 5 7.83 4.79 63.47%
2020-11-28 6 10 5 7.83 4.29 82.52%
2020-10-30 6 10 5 7.83 2.75 184.73%
2020-07-04 5 10 5 7.60 1.83 315.3%
2020-05-27 5 10 5 7.60 1.80 322.22%

IDRA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 0 0 3 0 0 3

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • Idera Pharmaceuticals Inc's number of analysts covering the stock is higher than nearly none of all US stocks.
  • IDRA has a lower variance in analysts' estimates than almost 100% of all US stocks.
  • Idera Pharmaceuticals Inc's average analyst price target is greater than 0.55% of all US stocks.
  • IDRA has a higher upside potential (average analyst target price relative to current price) than 3.94% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Idera Pharmaceuticals Inc are ACOR, RGLS and BLCM.

Make investment decisions regarding IDRA using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8411 seconds.